Please login to the form below

Not currently logged in
Email:
Password:

UK landmarks turn pink for breast cancer

Breast Cancer Campaign encourages people to Wear It Pink
Gateshead Millennium Bridge

The Millennium Bridge in Gateshead

Several major UK landmarks turned pink this week in support of a breast cancer campaign.

Iconic buildings and structures including London's Oxo Tower, the Falkirk Wheel and Gateshead's Millennium Bridge, all changed colour to promote today's Wear It Pink day, run by the charity Breast Cancer Campaign.

The campaign encourages men and women across the country to incorporate pink into their fashion choice for the day to raise awareness of breast cancer to encourage fundraiser for research.

In order to promote the day Breast Cancer Campaign organised for 18 landmarks across nine towns and cities to be bathed in a pink light.

“By turning pink in support of Breast Cancer Campaign and wear it pink, all of these iconic landmarks are helping us to remind the nation of the importance of funding breast cancer research,” said Danielle Atkinson, head of public fundraising at Breast Cancer Campaign.

Falkirk Wheel Wear It Pink
The Falkirk Wheel

The Wear It Pink campaign has so far raised more than £25m for breast cancer research and Breast Cancer Campaign has enlisted several well-known figures, including Olympic swimmer Rebecca Adlington and singer Eliza Doolittle to support the 2014 campaign.

The money goes to research projects across different aspects of breast cancer, including risk and prevention, understanding the genetic drivers and diagnosis.

• See more photos of UK landmarks wearing it pink.

24th October 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...